Northwestern Mutual Investment Management Company LLC reduced its stake in shares of DaVita HealthCare Partners Inc. (NYSE:DVA) by 1.6% during the second quarter, Holdings Channel reports. The firm owned 6,224 shares of the company’s stock after selling 102 shares during the period. Northwestern Mutual Investment Management Company LLC’s holdings in DaVita HealthCare Partners were worth $481,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of DVA. Vanguard Group Inc. boosted its stake in shares of DaVita HealthCare Partners by 0.4% in the second quarter. Vanguard Group Inc. now owns 14,730,050 shares of the company’s stock valued at $1,138,928,000 after buying an additional 60,767 shares during the period. BlackRock Institutional Trust Company N.A. boosted its stake in shares of DaVita HealthCare Partners by 0.3% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 4,650,954 shares of the company’s stock valued at $341,287,000 after buying an additional 15,468 shares during the period. BlackRock Fund Advisors boosted its stake in shares of DaVita HealthCare Partners by 6.1% in the second quarter. BlackRock Fund Advisors now owns 4,465,512 shares of the company’s stock valued at $345,273,000 after buying an additional 258,642 shares during the period. FMR LLC boosted its stake in shares of DaVita HealthCare Partners by 6.4% in the second quarter. FMR LLC now owns 4,128,469 shares of the company’s stock valued at $319,214,000 after buying an additional 247,358 shares during the period. Finally, Principal Financial Group Inc. boosted its stake in shares of DaVita HealthCare Partners by 11.1% in the second quarter. Principal Financial Group Inc. now owns 2,704,312 shares of the company’s stock valued at $209,097,000 after buying an additional 269,231 shares during the period. Institutional investors and hedge funds own 83.65% of the company’s stock.

Shares of DaVita HealthCare Partners Inc. (NYSE:DVA) opened at 64.44 on Monday. The firm has a market capitalization of $13.33 billion, a P/E ratio of 37.49 and a beta of 1.07. The company has a 50-day moving average price of $68.99 and a 200-day moving average price of $73.34. DaVita HealthCare Partners Inc. has a 12-month low of $61.36 and a 12-month high of $78.94.

DaVita HealthCare Partners (NYSE:DVA) last released its quarterly earnings data on Monday, August 8th. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.98 by $0.03. DaVita HealthCare Partners had a net margin of 2.51% and a return on equity of 16.48%. The business earned $3.72 billion during the quarter, compared to analyst estimates of $3.67 billion. During the same period in the previous year, the business earned $0.95 EPS. DaVita HealthCare Partners’s revenue was up 8.2% compared to the same quarter last year. Equities analysts predict that DaVita HealthCare Partners Inc. will post $3.76 EPS for the current year.

DVA has been the subject of several recent research reports. Bank of America Corp. cut DaVita HealthCare Partners from a “buy” rating to a “neutral” rating and set a $70.00 price target for the company. in a research note on Tuesday, September 6th. TheStreet cut DaVita HealthCare Partners from a “buy” rating to a “hold” rating in a research note on Monday, August 8th. Zacks Investment Research cut DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a research note on Monday, July 18th. Citigroup Inc. began coverage on DaVita HealthCare Partners in a research note on Tuesday, September 6th. They set a “neutral” rating and a $71.00 target price for the company. Finally, Wells Fargo & Co. restated a “buy” rating on shares of DaVita HealthCare Partners in a research note on Saturday, June 4th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. DaVita HealthCare Partners has a consensus rating of “Hold” and a consensus target price of $76.50.

In other news, insider Jeanine Marie Jiganti sold 1,291 shares of the business’s stock in a transaction on Monday, July 11th. The shares were sold at an average price of $78.51, for a total transaction of $101,356.41. Following the completion of the transaction, the insider now directly owns 5,716 shares in the company, valued at approximately $448,763.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Michael David Staffieri sold 20,262 shares of the business’s stock in a transaction on Tuesday, August 9th. The shares were sold at an average price of $73.09, for a total transaction of $1,480,949.58. Following the transaction, the chief operating officer now owns 52,279 shares of the company’s stock, valued at $3,821,072.11. The disclosure for this sale can be found here. 2.10% of the stock is currently owned by corporate insiders.

About DaVita HealthCare Partners

DaVita HealthCare Partners Inc is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. Its segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. Its Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD).

5 Day Chart for NYSE:DVA

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita HealthCare Partners Inc. (NYSE:DVA).

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.